Home / Issues / Press release

Press release

2005, 2016

Creating the conditions for universal access to new Hepatitis C treatments

20 May 2016|

Since 2014, the introduction of new Direct-Acting Antiviral (DAA) drugs has considerably changed the way hepatitis C infections are treated. These new highly-effective and well-tolerated treatments have enabled a sustained virologic response to be obtained Lire la suite

810, 2012

Blood donation: the French National AIDS Council is glad that blood donor selection criteria will be reviewed

8 October 2012|

On World Blood Donor Day on 14 June 2012, Marisol Touraine, the French Minister for Social Affairs and Health, announced that blood donor selection criteria are to be reviewed in the near future. The minister Lire la suite

2007, 2012

French National AIDS Council presentations and issues at stake at the Washington international conference

20 July 2012|

The XIX International AIDS Conference on 22-27 July in Washington is due to be attended by over 20,000 delegates and constitutes a major gathering for those working worldwide to combat the epidemic. Apart from being Lire la suite

1605, 2012

French National AIDS Council calls for HIV/AIDS control measures to be scaled up on the eve of Camp David G8 Summit

16 May 2012|

The President of France will take part in the G8 summit at Camp David on 18-19 May. In its 12 April 2012 declaration released during the meeting of G8 foreign affairs ministers, the American presidency Lire la suite

1105, 2012

French National AIDS Council issues opinion on the potential benefits of the concept of HIV/AIDS Pre-Exposure Prophylaxis (PrEP)

11 May 2012|

The concept of pre-exposure prophylaxis (PrEP) is a new HIV prevention method and is based on using antiretroviral treatments, used until now to treat infected people, to reduce the risk of HIV infection among non-infected Lire la suite

1105, 2012

French National AIDS Council issues opinion on the potential benefits of the concept of HIV/AIDS Pre-Exposure Prophylaxis (PrEP)

11 May 2012|

The CNS wishes to publish this opinion today, at a time when a committee of experts recommended the FDA to approve a supplemental New Drug Application for an antiretroviral treatment to be used for PrEP. Lire la suite